Results 61 to 70 of about 22,998 (167)
Quality of life in pediatric patients with tricuspid valve replacement
The article presents the results of the assessment of 52 patients' quality of life that had tricuspid valve prosthesis at the age from 1 to 16 years. Quality of life was evaluated by using a Nottingham Health Profile questionnaire.
Yu. N. Gorbatykh +8 more
doaj +1 more source
ABSTRACT Introduction For more than four decades, the AMS‐800 has remained the clinical benchmark device for the treatment of male stress urinary incontinence (SUI). Although it remains the gold standard for male SUI, the AMS‐800 has continued to have limitations such as suboptimal post‐operative continence rates, fixed hydraulic pressure, need for ...
Erin C. Schnell +2 more
wiley +1 more source
An overview and categorization of man‐made per‐ or polyfluoroalkyl substances (PFASs) including low‐molar‐mass and high‐molar‐mass fluorochemicals, and their international regulations is presented. Though certain PFASs are toxic, bioaccumulative and cross the human cellular membranes, others, such as fluoropolymers, are safe, reliable and involved in ...
Bruno Améduri
wiley +1 more source
In vitro study of a biological prosthetic valve for seamless fixation
Aim: to evaluate the manipulative properties of the system being developed for cardiac valve re-operation on an in vitro bovine heart model.Material and methods.
K. U. Klyshnikov +7 more
doaj +1 more source
The incidence of mechanical valve thrombosis (MVT) is around 0.4 per 100 patient-years. Mitral valve thrombosis has a higher incidence than aortic valve thrombosis with a nearly 5-fold increase. Various factors contribute to MVT. The most common cause of
Mazin O. Khalid MBBS +6 more
doaj +1 more source
Preventable geometric failure modes, such as outflow graft kinking and inflow malposition, frequently cause HeartMate 3 dysfunction. This study identifies these complications as key drivers of device‐related morbidity, highlighting the importance of optimized surgical positioning to ensure long‐term device performance and improved clinical outcomes ...
Ali Saad Merzah +17 more
wiley +1 more source
Late outcome analysis of the Braile Biomédica® pericardial valve in the aortic position
Objective: Aortic valve replacement with Braile bovine pericardial prosthesis has been routinely done at the Heart Institute of the Universidade de São Paulo Medical School since 2006.
Lisandro Gonçalves Azeredo +5 more
doaj +1 more source
In this series of 19 DCD donors using TA‐NRP, 89.5% of hearts were successfully transplanted with no PGD, no postoperative ECMO, and no 30‐day mortality, demonstrating the feasibility and safety of this approach. ABSTRACT Controlled donation after circulatory death (cDCD) with thoracoabdominal normothermic regional perfusion (TA‐NRP) has emerged ...
Maria Benedetto +11 more
wiley +1 more source
Successful Fibrinolytic Therapy in a Challenging Obstructive Prosthetic Mitral Valve Thrombosis
Prosthetic valve thrombosis is a rare and severe complication of the mechanical prosthetic valve. Management can be challenging due to varying clinical presentation, overlapping features of differential diagnosis, and lack of randomized controlled trials
Amr Essa MD +2 more
doaj +1 more source
HeartWare‐BiVAD was associated with more frequent right ventricular cannulation, whereas HM3‐BiVAD demonstrated a trend toward improved survival despite a more severe preimplant clinical profile, suggesting a potential device‐related advantage of HM3 in biventricular support.
Daler Rahimov +10 more
wiley +1 more source

